2.0
19. Sept. 2008
Aktueller Mitarbeiter
Raleigh, NC
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Allows you to help people everyday that can not afford the best in class meds.
Kontras
Future is weak. No new meds coming out because of poor performance of the R&D Department and the lack of senior leaders to purchase meds from other organizations that have been seccessfull in development.